Citations (327)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Michelle I. Jakobsen, Julie P. Schaug, Jimmi Nielsen & Erik Simonsen. (2023) Antipsychotic prescribing practices for outpatients with schizophrenia and reasons for non-clozapine treatment - Data from a Danish quality assessment audit. Nordic Journal of Psychiatry 77:5, pages 481-490.
Read now
Read now
Yu Funahashi, Yuta Yoshino, Jun-ichi Iga & Shu-ichi Ueno. (2023) Impact of clozapine on the expression of miR-675-3p in plasma exosomes derived from patients with schizophrenia. The World Journal of Biological Psychiatry 24:4, pages 303-313.
Read now
Read now
Sharon Taub, Amir Krivoy, Eromona Whiskey & Sukhi S. Shergill. (2022) New approaches to antipsychotic medication adherence – safety, tolerability and acceptability. Expert Opinion on Drug Safety 21:4, pages 517-524.
Read now
Read now
Zarrin Ansari, Sudhir Pawar & Rajmohan Seetharaman. (2022) Neuroinflammation and oxidative stress in schizophrenia: are these opportunities for repurposing?. Postgraduate Medicine 134:2, pages 187-199.
Read now
Read now
Andreea Teodorescu, Petru Ifteni, Ana Dragan, Marius Alexandru Moga, Ana Aliana Miron & Lorena Dima. (2021) Clozapine Efficacy in a Case of Severe Treatment-Resistant Postpartum Psychosis. Risk Management and Healthcare Policy 14, pages 555-559.
Read now
Read now
Wenying Yi, Shenglin She, Jie Zhang, Haibo Wu, Yingjun Zheng & Yuping Ning. (2020) Clozapine Use in Patients with Early-Stage Schizophrenia in a Chinese Psychiatric Hospital. Neuropsychiatric Disease and Treatment 16, pages 2827-2836.
Read now
Read now
Kenya A. Costa-Dookhan, Sri Mahavir Agarwal, Araba Chintoh, Veronica N. Tran, Nicolette Stogios, Bjørn H. Ebdrup, Sanjeev Sockalingam, Tarek K. Rajji, Gary J. Remington, Dan Siskind & Margaret K. Hahn. (2020) The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy. Expert Opinion on Drug Safety 19:1, pages 43-57.
Read now
Read now
Christoph U Correll, Thomas Brevig & Cecilia Brain. (2019) Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists. Neuropsychiatric Disease and Treatment 15, pages 3461-3473.
Read now
Read now
Oddur Ingimarsson, James H. MacCabe & Engilbert Sigurdsson. (2018) Constipation, ileus and medication use during clozapine treatment in patients with schizophrenia in Iceland. Nordic Journal of Psychiatry 72:7, pages 497-500.
Read now
Read now
John Lally, Fiona Gaughran, Philip Timms & Sarah R Curran. (2016) Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics. Pharmacogenomics and Personalized Medicine 9, pages 117-129.
Read now
Read now
Shyam Sundar Arumugham, Jagadisha Thirthalli & Chittaranjan Andrade. (2016) Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia. Expert Review of Clinical Pharmacology 9:9, pages 1245-1252.
Read now
Read now
Maren Carbon & Christoph U. Correll. (2014) Clinical predictors of therapeutic response to antipsychotics in schizophrenia. Dialogues in Clinical Neuroscience 16:4, pages 505-524.
Read now
Read now
Josiane Bourque, Nadia Lakis, Julie Champagne, Emmanuel Stip, Pierre Lalonde, Olivier Lipp & Adrianna Mendrek. (2013) Clozapine and visuospatial processing in treatment-resistant schizophrenia. Cognitive Neuropsychiatry 18:6, pages 615-630.
Read now
Read now
Jian-Ping Zhang & Anil K Malhotra. (2013) Pharmacogenetics of antipsychotics: recent progress and methodological issues. Expert Opinion on Drug Metabolism & Toxicology 9:2, pages 183-191.
Read now
Read now
Adel Gabriel. (2010) Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study. Neuropsychiatric Disease and Treatment 6, pages 711-717.
Read now
Read now
Pietro Gareri, Pasquale De Fazio, Emilio Russo, Norma Marigliano, Salvatore De Fazio & Giovambattista De Sarro. (2008) The safety of clozapine in the elderly. Expert Opinion on Drug Safety 7:5, pages 525-538.
Read now
Read now
Articles from other publishers (311)
Rowena Jones, Isabel Morales-Munoz, Adrian Shields, Graham Blackman, Sophie E. Legge, Megan Pritchard, Daisy Kornblum, James H. MacCabe & Rachel Upthegrove. (2023) Early neutrophil trajectory following clozapine may predict clozapine response – Results from an observational study using electronic health records. Brain, Behavior, and Immunity 113, pages 267-274.
Crossref
Crossref
Suriati Mohamed Saini, Chad A. Bousman, Serafino G. Mancuso, Vanessa Cropley, Tamsyn E. Van Rheenen, Rhoshel K. Lenroot, Jason Bruggemann, Cynthia S. Weickert, Thomas W. Weickert, Suresh Sundram, Ian P. Everall & Christos Pantelis. (2023) Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia. Schizophrenia 9:1.
Crossref
Crossref
Y. Saleh, I. Jarratt-Barnham, P. Petitet, E. Fernandez-Egea, S. G. Manohar & M. Husain. (2023) Negative symptoms and cognitive impairment are associated with distinct motivational deficits in treatment resistant schizophrenia. Molecular Psychiatry.
Crossref
Crossref
Pramod Chandru & Naren Gunja. (2023) Toxicity and Adverse Effects in Clozapine-Related Presentations to a Medical Toxicology Service in Western Sydney. Journal of Medical Toxicology.
Crossref
Crossref
Joshua Han, Stephen Allison, Jeffrey C.L. Looi, Sherry Kit Wa Chan & Tarun Bastiampillai. (2023) A systematic review of the role of clozapine for severe borderline personality disorder. Psychopharmacology.
Crossref
Crossref
Licia Vellucci, Mariateresa Ciccarelli, Elisabetta Filomena Buonaguro, Michele Fornaro, Giordano D’Urso, Giuseppe De Simone, Felice Iasevoli, Annarita Barone & Andrea de Bartolomeis. (2023) The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia. Biomolecules 13:8, pages 1220.
Crossref
Crossref
Eduardo A. Maury, Maxwell A. Sherman, Giulio Genovese, Thomas G. Gilgenast, Tushar Kamath, S.J. Burris, Prashanth Rajarajan, Erin Flaherty, Schahram Akbarian, Andrew Chess, Steven A. McCarroll, Po-Ru Loh, Jennifer E. Phillips-Cremins, Kristen J. Brennand, Evan Z. Macosko, James T.R. Walters, Michael O’Donovan, Patrick Sullivan, Jonathan Sebat, Eunjung A. Lee, Christopher A. Walsh, Christian R. Marshall, Daniele Merico, Bhooma Thiruvahindrapuram, Zhouzhi Wang, Stephen W. Scherer, Daniel P Howrigan, Stephan Ripke, Brendan Bulik-Sullivan, Kai-How Farh, Menachem Fromer, Jacqueline I. Goldstein, Hailiang Huang, Phil Lee, Mark J. Daly, Benjamin M. Neale, Richard A. BelliveauJr.Jr., Sarah E. Bergen, Elizabeth Bevilacqua, Kimberley D. Chambert, Colm O'Dushlaine, Edward M. Scolnick, Jordan W. Smoller, Jennifer L. Moran, Aarno Palotie, Tracey L. Petryshen, Wenting Wu, Douglas S. Greer, Danny Antaki, Aniket Shetty, Madhusudan Gujral, William M. Brandler, Dheeraj Malhotra, Karin V. Fuentes Fajarado, Michelle S. Maile, Peter A. Holmans, Noa Carrera, Nick Craddock, Valentina Escott-Price, Lyudmila Georgieva, Marian L. Hamshere, David Kavanagh, Sophie E. Legge, Andrew J. Pocklington, Alexander L. Richards, Douglas M. Ruderfer, Nigel M. Williams, George Kirov, Michael J. Owen, Dalila Pinto, Guiqing Cai, Kenneth L. Davis, Elodie Drapeau, Joseph I Friedman, Vahram Haroutunian, Elena Parkhomenko, Abraham Reichenberg, Jeremy M. Silverman, Joseph D. Buxbaum, Enrico Domenici, Ingrid Agartz, Srdjan Djurovic, Morten Mattingsdal, Ingrid Melle, Ole A. Andreassen, Erik G. Jönsson, Erik Söderman, Margot Albus, Madeline Alexander, Claudine Laurent, Douglas F. Levinson, Farooq Amin, Joshua Atkins, Murray J. Cairns, Rodney J. Scott, Paul A. Tooney, Jing Qin Wu, Silviu A. Bacanu, Tim B. Bigdeli, Mark A. Reimers, Bradley T. Webb, Aaron R. Wolen, Brandon K. Wormley, Kenneth S. Kendler, Brien P. Riley, Anna K. Kähler, Patrik K.E. Magnusson, Christina M. Hultman, Marcelo Bertalan, Thomas Hansen, Line Olsen, Henrik B. Rasmussen, Thomas Werge, Manuel Mattheisen, Donald W. Black, Richard Bruggeman, Nancy G. Buccola, Randy L. Buckner, Joshua L. Roffman, William Byerley, Wiepke Cahn, René S Kahn, Eric Strengman, Roel A. Ophoff, Vaughan J. Carr, Stanley V. Catts, Frans A. Henskens, Carmel M. Loughland, Patricia T. Michie, Christos Pantelis, Ulrich Schall, Assen V. Jablensky, Brian J. Kelly, Dominique Campion, Rita M. Cantor, Wei Cheng, C. Robert Cloninger, Dragan M Svrakic, David Cohen, Paul Cormican, Gary Donohoe, Derek W. Morris, Aiden Corvin, Michael Gill, Benedicto Crespo-Facorro, James J. Crowley, Martilias S. Farrell, Paola Giusti-Rodríguez, Yunjung Kim, Jin P. Szatkiewicz, Stephanie Williams, David Curtis, Jonathan Pimm, Hugh Gurling, Andrew McQuillin, Michael Davidson, Mark Weiser, Franziska Degenhardt, Andreas J. Forstner, Stefan Herms, Per Hoffmann, Andrea Hofman, Sven Cichon, Markus M. Nöthen, Jurgen Del Favero, Lynn E. DeLisi, Robert W. McCarley, Deborah L. Levy, Raquelle I. Mesholam-Gately, Larry J. Seidman, Dimitris Dikeos, George N. Papadimitriou, Timothy Dinan, Jubao Duan, Alan R. Sanders, Pablo V. Gejman, Elliot S. Gershon, Frank Dudbridge, Peter Eichhammer, Johan Eriksson, Veikko Salomaa, Laurent Essioux, Ayman H. Fanous, James A. Knowles, Michele T. Pato, Carlos N. Pato, Josef Frank, Sandra Meier, Thomas G. Schulze, Jana Strohmaier, Stephanie H. Witt, Marcella Rietschel, Lude Franke, Juha Karjalainen, Robert Freedman, Ann Olincy, Nelson B. Freimer, Shaun M. Purcell, Panos Roussos, Eli A. Stahl, Pamela Sklar, Jordan W. Smoller, Ina Giegling, Annette M. Hartmann, Bettina Konte, Dan Rujescu, Stephanie Godard, Joel N. Hirschhorn, Tune H. Pers, Alkes Price, Tõnu Esko, Jacob Gratten, S. Hong Lee, Peter M. Visscher, Naomi R. Wray, Bryan J. Mowry, Lieuwe de Haan, Carin J. Meijer, Mark Hansen, Masashi Ikeda, Nakao Iwata, Inge Joa, Luba Kalaydjieva, Matthew C. Keller, James L. Kennedy, Clement C. Zai, Jo Knight, Bernard Lerer, Kung-Yee Liang, Jeffrey Lieberman, T. Scott Stroup, Jouko Lönnqvist, Jaana Suvisaari, Brion S. Maher, Wolfgang Maier, Jacques Mallet, Colm McDonald, Andrew M. McIntosh, Douglas H.R. Blackwood, Andres Metspalu, Lili Milani, Vihra Milanova, Younes Mokrab, David A. Collier, Bertram Müller-Myhsok, Kieran C. Murphy, Robin M. Murray, John Powell, Inez Myin-Germeys, Jim Van Os, Igor Nenadic, Deborah A. Nertney, Gerald Nestadt, Ann E. Pulver, Kristin K. Nicodemus, Laura Nisenbaum, Annelie Nordin, Rolf Adolfsson, Eadbhard O'Callaghan, Sang-Yun Oh, F. Anthony O'Neill, Tiina Paunio, Olli Pietiläinen, Diana O. Perkins, Digby Quested, Adam Savitz, Qingqin S. Li, Sibylle G. Schwab, Jianxin Shi, Chris C.A. Spencer, Srinivas Thirumalai, Juha Veijola, John Waddington, Dermot Walsh, Dieter B. Wildenauer, Elvira Bramon, Ariel Darvasi, Danielle Posthuma, David St. Clair, Omar Shanta, Marieke Klein, Peter J. Park, Daniel Weinberger, John V. Moran, Fred H. Gage, Flora M. Vaccarino, Joseph Gleeson, Gary Mathern, Eric Courchesne, Subhojit Roy, Sara Bizzotto, Michael Coulter, Caroline Dias, Alissa D'Gama, Javier Ganz, Robert Hill, August Yue Huang, Sattar Khoshkhoo, Sonia Kim, Michael Lodato, Michael Miller, Rebeca Borges-Monroy, Rachel Rodin, Zinan Zhou, Craig Bohrson, Chong Chu, Isidro Cortes-Ciriano, Yanmei Dou, Alon Galor, Doga Gulhan, Minseok Kwon, Joe Luquette, Vinay Viswanadham, Attila Jones, Chaggai Rosenbluh, Sean Cho, Ben Langmead, Jeremy Thorpe, Jennifer Erwin, Andrew Jaffe, Michael McConnell, Rujuta Narurkar, Apua Paquola, Jooheon Shin, Richard Straub, Alexej Abyzov, Taejeong Bae, Yeongjun Jang, Yifan Wang, Fred Gage, Sara Linker, Patrick Reed, Meiyan Wang, Alexander Urban, Bo Zhou, Xiaowei Zhu, Reenal Pattni, Aitor Serres Amero, David Juan, Irene Lobon, Tomas Marques-Bonet, Manuel Solis Moruno, Raquel Garcia Perez, Inna Povolotskaya, Eduardo Soriano, Danny Antaki, Dan Averbuj, Laurel Ball, Martin Breuss, Xiaoxu Yang, Changuk Chung, Sarah B. Emery, Diane A. Flasch, Jeffrey M. Kidd, Huira C. Kopera, Kenneth Y. Kwan, Ryan E. Mills, John B. Moldovan, Chen Sun, Xuefang Zhao, Weichen Zhou, Trenton J. Frisbie, Adriana Cherskov, Liana Fasching, Alexandre Jourdon, Sirisha Pochareddy, Soraya Scuderi & Nenad Sestan. (2023) Schizophrenia-associated somatic copy-number variants from 12,834 cases reveal recurrent NRXN1 and ABCB11 disruptions. Cell Genomics 3:8, pages 100356.
Crossref
Crossref
Subash Raj Susai, Melanie Föcking, David Mongan, Meike Heurich, Fiona Coutts, Alice Egerton, Tony Whetton, Inge Winter-van Rossum, Richard D Unwin, Thomas A Pollak, Mark Weiser, Marion Leboyer, Dan Rujescu, Jonah F Byrne, George W Gifford, Paola Dazzan, Nikolaos Koutsouleris, René S Kahn, David R Cotter & Philip McGuire. (2023) Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial. Schizophrenia Bulletin 49:4, pages 893-902.
Crossref
Crossref
Kevin S. O'Connell, Elise Koch, Hasan Çağın Lenk, Ibrahim A Akkouh, Guy Hindley, Piotr Jaholkowski, Robert Løvsletten Smith, Børge Holen, Alexey A. Shadrin, Oleksandr Frei, Olav B. Smeland, Nils Eiel Steen, Anders M. Dale, Espen Molden, Srdjan Djurovic & Ole A. Andreassen. (2023) Polygenic overlap with body-mass index improves prediction of treatment-resistant schizophrenia. Psychiatry Research 325, pages 115217.
Crossref
Crossref
Jolanta Jaśkowska, Anna Karolina Drabczyk, Damian Kułaga, Przemysław Zaręba, Zbigniew Majka & Przemysław Jodłowski. (2023) A new synthetic ultrasound-assisted method for dibenzoepines. Heliyon 9:7, pages e18319.
Crossref
Crossref
Dylan J. Kiltschewskij, William R. Reay, Michael P. Geaghan, Joshua R. Atkins, Alexandre Xavier, Xiajie Zhang, Oliver J. Watkeys, Vaughan J. Carr, Rodney J. Scott, Melissa J. Green & Murray J. Cairns. (2023) Alteration of DNA Methylation and Epigenetic Scores Associated with Features of Schizophrenia and Common Variant Genetic Risk. Biological Psychiatry.
Crossref
Crossref
Mujeeb U. Shad. (2023) Pharmacogenomic screening for agranulocytosis and efficacy with clozapine. Journal of Translational Genetics and Genomics 7:3, pages 141-65.
Crossref
Crossref
Olivier Corbeil, Laurent Béchard, Émilien Fournier, Maude Plante, Marc-André Thivierge, Charles-Émile Lafrenière, Maxime Huot-Lavoie, Sébastien Brodeur, Anne-Marie Essiambre, Marc-André Roy & Marie-France Demers. (2023) Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review. Journal of Psychopharmacology 37:4, pages 370-377.
Crossref
Crossref
Judith M. Gault, Patrick Hosokawa, Daniel Kramer, Elyn R. Saks, Paul S. Appelbaum, John A. Thompson, Ann Olincy, Nicola Cascella, Akira Sawa, Wayne Goodman, Nidal Moukaddam, Sameer A. Sheth, William S. Anderson & Rachel A. Davis. (2023) Postsurgical morbidity and mortality favorably informs deep brain stimulation for new indications including schizophrenia and schizoaffective disorder. Frontiers in Surgery 10.
Crossref
Crossref
Miriam Olivola, Vincenzo Arienti, Nicola Bassetti, Gianluca Giovanna & Natascia Brondino. (2023) Lurasidone Augmentation of Clozapine in Refractory Schizophrenia. Journal of Clinical Psychopharmacology 43:2, pages 157-160.
Crossref
Crossref
Brian Dean, Geor Bakker, Hiroki R. Ueda, Andrew B. Tobin, Alastair Brown & Richard A. A. Kanaan. (2023) A growing understanding of the role of muscarinic receptors in the molecular pathology and treatment of schizophrenia. Frontiers in Cellular Neuroscience 17.
Crossref
Crossref
Cheryl GreenCheryl Green. 2023. Social Justice Case Studies. Social Justice Case Studies
131
208
.
Emanuele F. Osimo, Benjamin I. Perry, Pavan Mallikarjun, Megan Pritchard, Jonathan Lewis, Asia Katunda, Graham K. Murray, Jesus Perez, Peter B. Jones, Rudolf N. Cardinal, Oliver D. Howes, Rachel Upthegrove & Golam M. Khandaker. (2023) Predicting treatment resistance from first-episode psychosis using routinely collected clinical information. Nature Mental Health 1:1, pages 25-35.
Crossref
Crossref
Mishal Qubad & Robert A. Bittner. (2023) Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia. Therapeutic Advances in Psychopharmacology 13, pages 204512532311581.
Crossref
Crossref
Abhinav Chichra, Niji Rachel VarugheseRaviteja Innamuri. (2022) De Novo Seizures, Obsessive Compulsive Symptoms and Neutropenias in Patients on Clozapine: A Retrospective Cohort Study. Indian Journal of Psychological Medicine 45:1, pages 33-37.
Crossref
Crossref
Fengmei Fan, Junchao Huang, Shuping Tan, Zhiren Wang, Yanli Li, Song Chen, Hui Li, Stephanie Hare, Xiaoming Du, Fude Yang, Baopeng Tian, Peter Kochunov, Yunlong Tan & L. Elliot Hong. (2022) Association of cortical thickness and cognition with schizophrenia treatment resistance. Psychiatry and Clinical Neurosciences 77:1, pages 12-19.
Crossref
Crossref
Kazutoshi Kitajima, Shunsuke Tamura, Daiki Sasabayashi, Shinichiro Nakajima, Yusuke Iwata, Fumihiko Ueno, Yoshifumi Takai, Junichi Takahashi, Fernando Caravaggio, Wanna Mar, Edgardo Torres‐Carmona, Yoshihiro Noda, Philip Gerretsen, Vincenzo de Luca, Masaru Mimura, Shogo Hirano, Tomohiro Nakao, Toshiaki Onitsuka, Gary Remington, Ariel Graff‐Guerrero & Yoji Hirano. (2022)
Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with
treatment‐resistant
and
ultratreatment‐resistant
schizophrenia
. Psychiatry and Clinical Neurosciences 77:1, pages 2-11.
Crossref
Crossref
L.S. Dominicus, L. van Rijn, J. van der A, R. van der Spek, D. Podzimek, M. Begemann, L. de Haan, M. van der Pluijm, W.M. Otte, W. Cahn, C.H. Röder, H.G. Schnack & E. van Dellen. (2023) fMRI connectivity as a biomarker of antipsychotic treatment response: A systematic review. NeuroImage: Clinical 40, pages 103515.
Crossref
Crossref
Francesco Matrisciano & Graziano Pinna. 2023. Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders. Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders
513
535
.
Jiang Li, Akane Yoshikawa, Ney Alliey-Rodriguez & Herbert Y. Meltzer. (2022) Schizophrenia risk loci from xMHC region were associated with antipsychotic response in chronic schizophrenic patients with persistent positive symptom. Translational Psychiatry 12:1.
Crossref
Crossref
John M. Kane, Bruce J. Kinon, Carlos Forray, Pedro Such, Aurélia Mittoux, Ole M. Lemming, Peter Hertel & Oliver D. Howes. (2022) Efficacy and safety of Lu AF35700 in treatment-resistant schizophrenia: A randomized, active-controlled trial with open-label extension. Schizophrenia Research 248, pages 271-278.
Crossref
Crossref
Ambu Pandey & Kamal Narayan Kalita. (2022) Treatment-resistant schizophrenia: How far have we traveled?. Frontiers in Psychiatry 13.
Crossref
Crossref
Laura Dellazizzo, Sabrina Giguère, Nayla Léveillé, Stéphane Potvin & Alexandre Dumais. (2022) A systematic review of relational-based therapies for the treatment of auditory hallucinations in patients with psychotic disorders. Psychological Medicine 52:11, pages 2001-2008.
Crossref
Crossref
Annie Blazer, K. N. Roy Chengappa, William Foran, Ashley C. Parr, Charles E. Kahn, Beatriz Luna & Deepak K. Sarpal. (2022) Changes in corticostriatal connectivity and striatal tissue iron associated with efficacy of clozapine for treatment‑resistant schizophrenia. Psychopharmacology 239:8, pages 2503-2514.
Crossref
Crossref
Abhiram Narasimhan Purohith, Shalaka Anand Chatorikar, Samir Kumar Praharaj, Rajeshkrishna Panambur Bhandary & Podila Satya Venkata Narasimha Sharma. (2022) Efficacy and safety of maintenance electroconvulsive therapy (M-ECT) in treatment-resistant schizophrenia: A case series. Asian Journal of Psychiatry 73, pages 103132.
Crossref
Crossref
Biswa Ranjan Mishra, Kanhaiyalal Agrawal, Tathagata Biswas, Debadatta Mohapatra, Santanu Nath & Rituparna Maiti. (2022) Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Regional Cerebral Blood Flow in Treatment-Resistant Schizophrenia: A Randomized Controlled Trial. Schizophrenia Bulletin 48:4, pages 814-825.
Crossref
Crossref
Kengo Yonezawa, Hideaki Tani, Shinichiro Nakajima, Nobuhiro Nagai, Teruki Koizumi, Tomoyuki Miyazaki, Masaru Mimura, Takuya Takahashi & Hiroyuki Uchida. (2022) AMPA receptors in schizophrenia: A systematic review of postmortem studies on receptor subunit expression and binding. Schizophrenia Research 243, pages 98-109.
Crossref
Crossref
Petros Drosos, Erik Johnsen, Christoffer Andreas Bartz-Johannessen, Tor Ketil Larsen, Solveig Klæbo Reitan, Maria Rettenbacher & Rune Andreas Kroken. (2022) Trajectories of response in schizophrenia-spectrum disorders: A one-year prospective cohort study of antipsychotic effectiveness. World Journal of Psychiatry 12:3, pages 521-532.
Crossref
Crossref
Hao Hu, Yuchao Jiang, Mengqing Xia, Yingying Tang, Tianhong Zhang, Huiru Cui, Junjie Wang, Lihua Xu, Adrian Curtin, Jianhua Sheng, Xinyi Cao, Qian Guo, Yuping Jia, Chunbo Li, Zhen Wang, Cheng Luo & Jijun Wang. (2022) Functional reconfiguration of cerebellum-cerebral neural loop in schizophrenia following electroconvulsive therapy. Psychiatry Research: Neuroimaging 320, pages 111441.
Crossref
Crossref
Caleb Labonté, Naista Zhand, Angela Park & Philip D. Harvey. (2022) Complete blood count inflammatory markers in treatment-resistant schizophrenia: Evidence of association between treatment responsiveness and levels of inflammation. Psychiatry Research 308, pages 114382.
Crossref
Crossref
Helen Killaspy, Carol Harvey, Catherine Brasier, Lisa Brophy, Priscilla Ennals, Justine Fletcher & Bridget Hamilton. (2022) Community‐based social interventions for people with severe mental illness: a systematic review and narrative synthesis of recent evidence. World Psychiatry 21:1, pages 96-123.
Crossref
Crossref
Daniel M.S. Rosenbaum, David Robertson & Samuel Law. (2022) Psychiatric Futility and Palliative Care for a Patient With Clozapine-resistant Schizophrenia. Journal of Psychiatric Practice 28:4, pages 344-348.
Crossref
Crossref
Silvia Moga, Andreea Teodorescu, Ana Dragan, Ana Aliana Miron & Petru Ifteni. (2022) Neutropenia in Patients With Clozapine-Treated Schizophrenia: An Effect of Clozapine or a Consequence of SARS-CoV-2 Infection? A Systematic Review. American Journal of Therapeutics 29:5, pages e544-e552.
Crossref
Crossref
Steven Parkes, Bethany Mantell, Ebenezer Oloyede & Graham Blackman. (2022) Patients’ Experiences of Clozapine for Treatment-Resistant Schizophrenia: A Systematic Review. Schizophrenia Bulletin Open 3:1.
Crossref
Crossref
Niamh M. Ryan, Cathal Ormond, Philip Brady, Elizabeth A. Heron & Aiden Corvin. 2022. Psychiatric Genomics. Psychiatric Genomics
17
41
.
Gerd Laux. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
11
.
Isabel Valli & Norma Verdolini. 2022. Prevention in Mental Health. Prevention in Mental Health
251
275
.
Gerd Laux. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1837
1846
.
Anika Poppe, Leonie Bais, Daniëlle van Duin, Branislava Ćurčić-Blake, Gerdina Hendrika Maria Pijnenborg & Lisette van der Meer. (2021) Improving cognition in severe mental illness by combining cognitive remediation and transcranial direct current stimulation: study protocol for a pragmatic randomized controlled pilot trial (HEADDSET). Trials 22:1.
Crossref
Crossref
Adam Jameson, Beth Fylan, Greg C. Bristow, Gurdeep S. Sagoo, Caroline Dalton, Alastair Cardno, Jaspreet Sohal & Samantha L. McLean. (2021) What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?. Frontiers in Genetics 12.
Crossref
Crossref
Gary Remington, Margaret K. Hahn, Sri Mahavir Agarwal, Araba Chintoh & Ofer Agid. (2021) Schizophrenia: Antipsychotics and drug development. Behavioural Brain Research 414, pages 113507.
Crossref
Crossref
Zoe Harrison, Owen Haeney & William Brereton. (2021) Augmentation of Antipsychotic Medications with Low-Dose Clozapine in Treatment-Resistant Schizophrenia—Case Reports and Discussion. Case Reports in Psychiatry 2021, pages 1-5.
Crossref
Crossref
Amanda J. Lisoway, Cheng C. Chen, Clement C. Zai, Arun K. Tiwari & James L. Kennedy. (2021) Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment. Schizophrenia Research 232, pages 112-124.
Crossref
Crossref
Emma Wellesley Wesley, India Patel, Giouliana Kadra-Scalzo, Megan Pritchard, Hitesh Shetty, Matthew Broadbent, Aviv Segev, Rashmi Patel, Johnny Downs, James H. MacCabe, Richard D. Hayes & Daniela Fonseca de Freitas. (2021) Gender disparities in clozapine prescription in a cohort of treatment-resistant schizophrenia in the South London and Maudsley case register. Schizophrenia Research 232, pages 68-76.
Crossref
Crossref
Faith Borgan, Mattia Veronese, Tiago Reis Marques, David J. Lythgoe & Oliver Howes. (2020) Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study. European Archives of Psychiatry and Clinical Neuroscience 271:4, pages 677-687.
Crossref
Crossref
Jean-Pierre Lindenmayer & Brianna Fitapelli. (2021) Noninvasive direct current stimulation for schizophrenia: a review. Current Opinion in Psychiatry 34:3, pages 253-259.
Crossref
Crossref
Alexandra I. Korda, Christina Andreou & Stefan Borgwardt. (2021) Pattern classification as decision support tool in antipsychotic treatment algorithms. Experimental Neurology 339, pages 113635.
Crossref
Crossref
Mélissa Beaudoin, Stéphane Potvin, Alexandra Machalani, Laura Dellazizzo, Lysandre Bourguignon, Kingsada Phraxayavong & Alexandre Dumais. (2021) The therapeutic processes of avatar therapy: A content analysis of the dialogue between treatment‐resistant patients with schizophrenia and their avatar. Clinical Psychology & Psychotherapy 28:3, pages 500-518.
Crossref
Crossref
Bettina Konte, James T. R. Walters, Dan Rujescu, Sophie E. Legge, Antonio F. Pardiñas, Dan Cohen, Munir Pirmohamed, Jari Tiihonen, Annette M. Hartmann, Jan P. Bogers, Jan van der Weide, Karen van der Weide, Anu Putkonen, Eila Repo-Tiihonen, Tero Hallikainen, Ed Silva, Oddur Ingimarsson, Engilbert Sigurdsson, James L. Kennedy, Patrick F. Sullivan, Marcella Rietschel, Gerome Breen, Hreinn Stefansson, Kari Stefansson, David A. Collier, Michael C. O’Donovan & Ina Giegling. (2021) HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry. Translational Psychiatry 11:1.
Crossref
Crossref
Lisette van der Meer, Tessa Jonker, Heleen Wadman, Charlotte Wunderink, Jaap van Weeghel, Gerdina Hendrika Maria Pijnenborg & Ellie R. H. van Setten. (2021) Targeting Personal Recovery of People With Complex Mental Health Needs: The Development of a Psychosocial Intervention Through User-Centered Design. Frontiers in Psychiatry 12.
Crossref
Crossref
Daniela Enache, Naghmeh Nikkheslat, Dina Fathalla, B. Paul Morgan, Shôn Lewis, Richard Drake, Bill Deakin, James Walters, Stephen M. Lawrie, Alice Egerton, James H. MacCabe & Valeria Mondelli. (2021) Peripheral immune markers and antipsychotic non-response in psychosis. Schizophrenia Research 230, pages 1-8.
Crossref
Crossref
Giulia Tronchin, Genevieve McPhilemy, Mohamed Ahmed, Liam Kilmartin, Laura Costello, Natalie J. Forde, Leila Nabulsi, Theophilus N. Akudjedu, Laurena Holleran, Brian Hallahan, Dara M. Cannon & Colm McDonald. (2021) White matter microstructure and structural networks in treatment-resistant schizophrenia patients after commencing clozapine treatment: A longitudinal diffusion imaging study. Psychiatry Research 298, pages 113772.
Crossref
Crossref
Sherry Kit Wa Chan, Hei Yan Veronica Chan, William G Honer, Tarun Bastiampillai, Yi Nam Suen, Wai Song Yeung, Ming Lam, Wing King Lee, Roger Man King Ng, Christy Lai Ming Hui, Wing Chung Chang, Edwin Ho Ming Lee & Eric Yu Hai Chen. (2021) Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders. Schizophrenia Bulletin 47:2, pages 485-494.
Crossref
Crossref
Alice Egerton, Anna Murphy, Jacek Donocik, Adriana Anton, Gareth J Barker, Tracy Collier, Bill Deakin, Richard Drake, Emma Eliasson, Richard Emsley, Catherine J Gregory, Kira Griffiths, Shitij Kapur, Laura Kassoumeri, Laura Knight, Emily J B Lambe, Stephen M Lawrie, Jane Lees, Shôn Lewis, David J Lythgoe, Julian Matthews, Philip McGuire, Lily McNamee, Scott Semple, Alexander D Shaw, Krish D Singh, Charlotte Stockton-Powdrell, Peter S Talbot, Mattia Veronese, Ernest Wagner, James T R Walters, Stephen R Williams, James H MacCabe & Oliver D Howes. (2021) Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA). Schizophrenia Bulletin 47:2, pages 505-516.
Crossref
Crossref
Jessica W. Y. Yuen, David D. Kim, Ric M. Procyshyn, William J. Panenka, William G. Honer & Alasdair M. Barr. (2021) A Focused Review of the Metabolic Side-Effects of Clozapine. Frontiers in Endocrinology 12.
Crossref
Crossref
Laura Dellazizzo, Stéphane Potvin, Kingsada Phraxayavong & Alexandre Dumais. (2021) One-year randomized trial comparing virtual reality-assisted therapy to cognitive–behavioral therapy for patients with treatment-resistant schizophrenia. npj Schizophrenia 7:1.
Crossref
Crossref
John Lally, Emily Breese, Mugtaba Osman, Cai Hua Sim, Hitesh Shetty, Amir Krivoy & James H. MacCabe. (2020) Augmentation of clozapine with ECT: a retrospective case analysis. Acta Neuropsychiatrica 33:1, pages 31-36.
Crossref
Crossref
Jiaxin Zeng, Wenjing Zhang, Yuan Xiao, Gui Fu, Lu Liu, Biqiu Tang, Na Hu, John A. Sweeney, Su Lui & Qiyong Gong. (2021) Pretreatment abnormalities in white matter integrity predict one-year clinical outcome in first episode schizophrenia. Schizophrenia Research 228, pages 241-248.
Crossref
Crossref
Kenya A. Costa-Dookhan, Tarek K. Rajji, Veronica N. Tran, Sylvie Bowden, Daniel J. Mueller, Gary J. Remington, Sri Mahavir Agarwal & Margaret K. Hahn. (2021) Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia. Scientific Reports 11:1.
Crossref
Crossref
Kirsten Jahn, Astrid Heese, Oussama Kebir, Adrian Groh, Stefan Bleich, Marie Odile Krebs & Helge Frieling. (2021) Differential Methylation Pattern of Schizophrenia Candidate Genes in Tetrahydrocannabinol-Consuming Treatment-Resistant Schizophrenic Patients Compared to Non-Consumer Patients and Healthy Controls. Neuropsychobiology 80:1, pages 36-44.
Crossref
Crossref
Rosalinda C. Roberts. (2021) Mitochondrial dysfunction in schizophrenia: With a focus on postmortem studies. Mitochondrion 56, pages 91-101.
Crossref
Crossref
Jason M Noel & Cherry W Jackson. (2020) ASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorder. American Journal of Health-System Pharmacy 77:24, pages 2114-2132.
Crossref
Crossref
Ádám Menus, Ádám Kiss, Katalin Tóth, Dávid Sirok, Máté Déri, Ferenc Fekete, Gábor Csukly & Katalin Monostory. (2020) Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia. Scientific Reports 10:1.
Crossref
Crossref
Claudio Ciprian, Kirill Masychev, Maryam Ravan, James P. Reilly & Duncan Maccrimmon. (2020) A Machine Learning Approach Using Effective Connectivity to Predict Response to Clozapine Treatment. IEEE Transactions on Neural Systems and Rehabilitation Engineering 28:12, pages 2598-2607.
Crossref
Crossref
Hitoshi Watanabe, Kyoji Ishida, Masanori Yamamoto, Masakuni Horiguchi & Yoshiaki Isobe. (2020) Synthesis and pharmacological evaluation of 11-(1,6-dimethyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepines with clozapine-like receptor occupancy at dopamine D1/D2 receptor. Bioorganic & Medicinal Chemistry Letters 30:21, pages 127563.
Crossref
Crossref
Bindu Rathod, Arveen Kaur, Deepak M Basavanagowda, Devyani Mohan, Nupur Mishra, Sehrish Fuad, Sadia Nosher, Zaid A Alrashid & Stacey E Heindl. (2020) Neurological Soft Signs and Brain Abnormalities in Schizophrenia: A Literature Review. Cureus.
Crossref
Crossref
Kawtar El Abdellati, Livia De Picker & Manuel Morrens. (2020) Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis. Frontiers in Neuroscience 14.
Crossref
Crossref
J. Corey Williams, Jenna Harowitz, Jan Glover, Cenk Tek & Vinod Srihari. (2020) Systematic review of racial disparities in clozapine prescribing. Schizophrenia Research 224, pages 11-18.
Crossref
Crossref
Xu You, Yunqiao Zhang, Qing Long, Zijun Liu, Xiao Ma, Zixiang Lu, Wei� Yang, Ziqiao Feng, Wengyu Zhang, Zhaowei Teng & Yong Zeng. (2020) Investigating aberrantly expressed microRNAs in peripheral blood mononuclear cells from patients with treatment‑resistant schizophrenia using miRNA sequencing and integrated bioinformatics. Molecular Medicine Reports.
Crossref
Crossref
Kirill Masychev, Claudio Ciprian, Maryam Ravan, Akshaya Manimaran & AnkitaAmol Deshmukh. (2020) Quantitative biomarkers to predict response to clozapine treatment using resting EEG data. Schizophrenia Research 223, pages 289-296.
Crossref
Crossref
R. Jones, J.H. MacCabe, M.J. Price, X. Liu & R. Upthegrove. (2020) Effect of age on the relative efficacy of clozapine in schizophrenia. Acta Psychiatrica Scandinavica 142:2, pages 109-120.
Crossref
Crossref
Giulia Tronchin, Theophilus N. Akudjedu, Mohamed Ahmed, Laurena Holleran, Brian Hallahan, Dara M. Cannon & Colm McDonald. (2020) Progressive subcortical volume loss in treatment-resistant schizophrenia patients after commencing clozapine treatment. Neuropsychopharmacology 45:8, pages 1353-1361.
Crossref
Crossref
Solomon Teferra. (2020) Initiating clozapine treatment service and characteristics of clozapine-treated patients in a general hospital in Addis Ababa, Ethiopia. South African Journal of Psychiatry 26.
Crossref
Crossref
Michael Frank Mørup, Steven M. Kymes & Daniel Oudin Åström. (2020) A modelling approach to estimate the prevalence of treatment-resistant schizophrenia in the United States. PLOS ONE 15:6, pages e0234121.
Crossref
Crossref
Judith M. Gault, John A. Thompson, Keeran Maharajh, Patrick Hosokawa, Karen E. Stevens, Ann Olincy, Erin I. Liedtke, Alex Ojemann, Steven Ojemann & Aviva Abosch. (2020) Striatal and Thalamic Auditory Response During Deep Brain Stimulation for Essential Tremor: Implications for Psychosis. Neuromodulation: Technology at the Neural Interface 23:4, pages 478-488.
Crossref
Crossref
Sophie E. Legge, Charlotte A. Dennison, Antonio F. Pardiñas, Elliott Rees, Amy J. Lynham, Lucinda Hopkins, Lesley Bates, George Kirov, Michael J. Owen, Michael C. O'Donovan & James T.R. Walters. (2019) Clinical indicators of treatment-resistant psychosis. The British Journal of Psychiatry 216:5, pages 259-266.
Crossref
Crossref
Roberta Rowntree, Sean Murray, Felicity Fanning, Dolores Keating, Atilla Szigeti, Roisin Doyle, Stephen McWilliams & Mary Clarke. (2020) Clozapine use – has practice changed?. Journal of Psychopharmacology 34:5, pages 567-573.
Crossref
Crossref
Herbert Y. Meltzer, Daniel B. Share, Karu Jayathilake, Ronald M. Salomon & Myung A. Lee. (2020) Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia. Journal of Clinical Psychopharmacology 40:3, pages 240-249.
Crossref
Crossref
Sobia Tariq, Muhammad Khalid, Abdul Rauf Raza, Syeda Laila Rubab, Sara Figueirêdo de Alcântara Morais, Muhammad Usman Khan, Muhammad Nawaz Tahir & Ataualpa Albert Carmo Braga. (2020) Experimental and computational investigations of new indole derivatives: A combined spectroscopic, SC-XRD, DFT/TD-DFT and QTAIM analysis. Journal of Molecular Structure 1207, pages 127803.
Crossref
Crossref
Maykel Farag Ghabrash, Stephanie Coronado-Montoya, John Aoun, Andrée-Anne Gagné, Flavi Mansour, Clairélaine Ouellet-Plamondon, Annie Trépanier & Didier Jutras-Aswad. (2020) Cannabidiol for the treatment of psychosis among patients with schizophrenia and other primary psychotic disorders: A systematic review with a risk of bias assessment. Psychiatry Research 286, pages 112890.
Crossref
Crossref
Sobia Tariq, Abdul Rauf Raza, Muhammad Khalid, Syeda Laila Rubab, Muhammad Usman Khan, Akbar Ali, Muhammad Nawaz Tahir & Ataualpa Albert Carmo Braga. (2020) Synthesis and structural analysis of novel indole derivatives by XRD, spectroscopic and DFT studies. Journal of Molecular Structure 1203, pages 127438.
Crossref
Crossref
Parita Shah, Yusuke Iwata, Eric E. Brown, Julia Kim, Marcos Sanches, Hiroyoshi Takeuchi, Shinichiro Nakajima, Margaret Hahn, Gary Remington, Philip Gerretsen & Ariel Graff-Guerrero. (2019) Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study. European Archives of Psychiatry and Clinical Neuroscience 270:1, pages 11-22.
Crossref
Crossref
Thomas Berry, Eid Abohamza & Ahmed A. Moustafa. (2020) Treatment-resistant schizophrenia: focus on the transsulfuration pathway. Reviews in the Neurosciences 31:2, pages 219-232.
Crossref
Crossref
Linnea Stenmark, Katarzyna Popiolek, Robert Bodén, Ole Brus, Åsa Hammar, Mikael Landén, Johan Lundberg, Pia Nordanskog & Axel Nordenskjöld. (2020) Predictors of Treatment Response to Electroconvulsive Therapy in Schizophrenia—A Nationwide Registry-Based Study. Schizophrenia Bulletin Open 1:1.
Crossref
Crossref
Megan Ichinose & Sohee Park. 2020. A Clinical Introduction to Psychosis. A Clinical Introduction to Psychosis
37
62
.
Sophie E. Legge, Antonio F. Pardiñas & James T.R. Walters. 2020. Personalized Psychiatry. Personalized Psychiatry
413
422
.
A. Corvin, C. Ormond & A.M. Cole. 2020. Personalized Psychiatry. Personalized Psychiatry
173
186
.
Oliver FreudenreichOliver Freudenreich. 2020. Psychotic Disorders. Psychotic Disorders
157
170
.
Christoph U. Correll, Thomas Brevig & Cecilia Brain. (2019) Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists. BMC Psychiatry 19:1.
Crossref
Crossref
Fulgencio Ruso-Julve, Ana Pombero, Fuencisla Pilar-Cuéllar, Nuria García-Díaz, Raquel Garcia-Lopez, María Juncal-Ruiz, Elena Castro, Álvaro Díaz, Javier Vazquez-Bourgón, Agustín García-Blanco, Emilio Garro-Martinez, Helena Pisonero, Alicia Estirado, Rosa Ayesa-Arriola, Juan López-Giménez, Federico MayorJr.Jr., Elsa Valdizán, Javier Meana, Javier Gonzalez-Maeso, Salvador Martínez, José Pedro Vaqué & Benedicto Crespo-Facorro. (2019) Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics. Translational Psychiatry 9:1.
Crossref
Crossref
P. Kirwan, L. O’Connor, K. Sharma & C. McDonald. (2017) The impact of switching to clozapine on psychiatric hospital admissions: a mirror-image study. Irish Journal of Psychological Medicine 36:4, pages 259-263.
Crossref
Crossref
G. Fond, O. Godin, L. Boyer, F. Berna, M. Andrianarisoa, N. Coulon, L. Brunel, E. Bulzacka, B. Aouizerate, D. Capdevielle, I. Chereau, T. D’Amato, C. Dubertret, J. Dubreucq, C. Faget, S. Leignier, C. Lançon, J. Mallet, D. Misdrahi, C. Passerieux, R. Rey, A. Schandrin, M. Urbach, P. Vidailhet, P. M. Llorca, F. Schürhoff & M. Leboyer. (2018) Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort. European Archives of Psychiatry and Clinical Neuroscience 269:8, pages 985-992.
Crossref
Crossref
Shabeesh Balan, Manabu Toyoshima & Takeo Yoshikawa. (2019) Contribution of induced pluripotent stem cell technologies to the understanding of cellular phenotypes in schizophrenia. Neurobiology of Disease 131, pages 104162.
Crossref
Crossref
Muhammad R. Baig. (2019) Low-Dose Lithium for Long-Term Treatment of Clozapine- Induced Neutropenia: A Case Series. Current Psychopharmacology 8:2, pages 155-158.
Crossref
Crossref
Marco Solmi, Michele Fornaro, Kuniyoshi Toyoshima, Andrè F. Carvalho, Cristiano A. Köhler, Nicola Veronese, Brendon Stubbs, Andrea de Bartolomeis & Christoph U. Correll. (2018) Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder. CNS Spectrums 24:5, pages 479-495.
Crossref
Crossref
Christiane Gasse, Theresa Wimberley, Yungpeng Wang, Ole Mors, Anders Børglum, Thomas Damm Als, Thomas Werge, Merete Nordentoft, David M. Hougaard & Henriette Thisted Horsdal. (2019) Schizophrenia polygenic risk scores, urbanicity and treatment-resistant schizophrenia. Schizophrenia Research 212, pages 79-85.
Crossref
Crossref
Dawn I. Velligan, Cecilia Brain, Laëtitia Bouérat Duvold & Ofer Agid. (2019) Caregiver Burdens Associated With Treatment-Resistant Schizophrenia: A Quantitative Caregiver Survey of Experiences, Attitudes, and Perceptions. Frontiers in Psychiatry 10.
Crossref
Crossref
Cheryl Cheuk-Yan Leung, Romayne Gadelrab, Chukwuma Uchenna Ntephe, Philip K. McGuire & Arsime Demjaha. (2019) Clinical Course, Neurobiology and Therapeutic Approaches to Treatment Resistant Schizophrenia. Toward an Integrated View. Frontiers in Psychiatry 10.
Crossref
Crossref
Eric Plitman, Elisa Guma, Martin Lepage, Jamie Near & M. Mallar Chakravarty. (2019) Using proton magnetic resonance spectroscopic imaging to study glutamatergic alterations in patients with schizophrenia: A systematic review. Schizophrenia Research 210, pages 13-20.
Crossref
Crossref
Yiwen Zhang, Lihua Xu, Yang Hu, Jinfeng Wu, Chunbo Li, Jijun Wang & Zhi Yang. (2019) Functional Connectivity Between Sensory-Motor Subnetworks Reflects the Duration of Untreated Psychosis and Predicts Treatment Outcome of First-Episode Drug-Naïve Schizophrenia. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 4:8, pages 697-705.
Crossref
Crossref
Faith R. Borgan, Sameer Jauhar, Robert A. McCutcheon, Fiona S. Pepper, Maria Rogdaki, David J. Lythgoe & Oliver D. Howes. (2019) Glutamate levels in the anterior cingulate cortex in un-medicated first episode psychosis: a proton magnetic resonance spectroscopy study. Scientific Reports 9:1.
Crossref
Crossref
Toby Pillinger, Maria Rogdaki, Robert A. McCutcheon, Pamela Hathway, Alice Egerton & Oliver D. Howes. (2019) Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications. Psychopharmacology 236:7, pages 1985-1997.
Crossref
Crossref
Henry A. Nasrallah, Rissa Fedora & Robert Morton. (2019) Successful treatment of clozapine-nonresponsive refractory hallucinations and delusions with pimavanserin, a serotonin 5HT-2A receptor inverse agonist. Schizophrenia Research 208, pages 217-220.
Crossref
Crossref
SeungJu Jackie Oh & Xiaoduo Fan. (2019) The Possible Role of the Angiotensin System in the Pathophysiology of Schizophrenia: Implications for Pharmacotherapy. CNS Drugs 33:6, pages 539-547.
Crossref
Crossref
Davide Amato, Anna Kruyer, Anne-Noël Samaha & Andreas Heinz. (2019) Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia. Frontiers in Psychiatry 10.
Crossref
Crossref
Maximilian Huhn, Myrto Samara & Stefan Leucht. (2019) Pharmakotherapie der therapieresistenten Schizophrenie. PSYCH up2date 13:03, pages 223-240.
Crossref
Crossref
Myrto T Samara, Adriani Nikolakopoulou, Georgia Salanti & Stefan Leucht. (2019) How Many Patients With Schizophrenia Do Not Respond to Antipsychotic Drugs in the Short Term? An Analysis Based on Individual Patient Data From Randomized Controlled Trials. Schizophrenia Bulletin 45:3, pages 639-646.
Crossref
Crossref
Alan F. Schatzberg & Charles DeBattista. 2019. Schatzberg’s Manual of Psychopharmacology. Schatzberg’s Manual of Psychopharmacology.
Diarmid JM Sinclair, Sai Zhao, Fang Qi, Kazare Nyakyoma, Joey SW Kwong & Clive E Adams. (2019) Electroconvulsive therapy for treatment-resistant schizophrenia. Cochrane Database of Systematic Reviews 2019:3.
Crossref
Crossref
Samantha Maryan, Michelle Harms, Erin McAllister & Beth DeJongh. (2019) Comparison of clozapine monitoring and adverse event management in a psychiatrist-only and a clinical pharmacist-psychiatrist collaborative clinic. Mental Health Clinician 9:2, pages 70-75.
Crossref
Crossref
Ignazio S Piras, Mirko Manchia, Matthew J Huentelman, Federica Pinna, Clement C Zai, James L Kennedy & Bernardo Carpiniello. (2019) Peripheral Biomarkers in Schizophrenia: A Meta-Analysis of Microarray Gene Expression Datasets. International Journal of Neuropsychopharmacology 22:3, pages 186-193.
Crossref
Crossref
Khaled Turkmani, Mohamad Essam Marwa, Basel Ahmad, Tareq Ahmad, Ali Alrstom & Adib Essali. (2019) Clozapine (generic versus branded) for people with schizophrenia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
J.P. Lindenmayer, Mila Kirstie C. Kulsa, Tania Sultana, Amandeep Kaur, Ran Yang, Isidora Ljuri, Benedicto Parker & Anzalee Khan. (2019) Transcranial direct-current stimulation in ultra-treatment-resistant schizophrenia. Brain Stimulation 12:1, pages 54-61.
Crossref
Crossref
. 2019. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
119
.
Wolfgang Gaebel, Alkomiet Hasan & Peter Falkai. 2019. S3-Leitlinie Schizophrenie. S3-Leitlinie Schizophrenie
51
137
.
A. Egerton, B. V. Broberg, N. Van Haren, K. Merritt, G. J. Barker, D. J. Lythgoe, R. Perez-Iglesias, L. Baandrup, S. W. Düring, K. V. Sendt, J. M. Stone, E. Rostrup, I. E. Sommer, B. Glenthøj, R. S. Kahn, P. Dazzan & P. McGuire. (2018) Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE). Molecular Psychiatry 23:11, pages 2145-2155.
Crossref
Crossref
Mary-Anne B. MacKay, John W. Paylor, James T. F. Wong, Ian R. Winship, Glen B. Baker & Serdar M. Dursun. (2018) Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics. Frontiers in Psychiatry 9.
Crossref
Crossref
Candice E. Crocker & Philip G. Tibbo. (2018) Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia. Frontiers in Pharmacology 9.
Crossref
Crossref
Grant McQueen, John Lally, Tracy Collier, Fernando Zelaya, David J. Lythgoe, Gareth J. Barker, James M. Stone, Philip McGuire, James H. MacCabe & Alice Egerton. (2018) Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia. Psychopharmacology 235:10, pages 3045-3054.
Crossref
Crossref
Shusuke Numata, Hidehiro Umehara, Tetsuro Ohmori & Ryota Hashimoto. (2018) Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis. Frontiers in Pharmacology 9.
Crossref
Crossref
Ruta Samanaite, Amy Gillespie, Kyra-Verena Sendt, Grant McQueen, James H. MacCabe & Alice Egerton. (2018) Biological Predictors of Clozapine Response: A Systematic Review. Frontiers in Psychiatry 9.
Crossref
Crossref
Herbert Y. Meltzer, Min Young Sim, Adam Anderson, Christopher Cannistraci, Karu Jayathilake, Daniel Barrett Share & Myung Lee. (2018) A within-subject consideration of the psychotic spectrum disorder concept in a patient in remission associated with cortical gray matter recovery. CNS Neuroscience & Therapeutics 24:7, pages 641-651.
Crossref
Crossref
Dılgeş Baskın, Yasin Çetinkaya & Metin Balci. (2018) Synthesis of dipyrrolo-diazepine derivatives via intramolecular alkyne cyclization. Tetrahedron 74:30, pages 4062-4070.
Crossref
Crossref
Courtney K. Walker, Joy K. Roche, Vidushi Sinha & Rosalinda C. Roberts. (2018) Substantia nigra ultrastructural pathology in schizophrenia. Schizophrenia Research 197, pages 209-218.
Crossref
Crossref
Clement C. Zai, Arun K. Tiwari, Gwyneth C. Zai, Miriam S. Maes & James L. Kennedy. (2018) New findings in pharmacogenetics of schizophrenia. Current Opinion in Psychiatry 31:3, pages 200-212.
Crossref
Crossref
Christy L M Hui, William G Honer, Edwin H M Lee, Wing Chung Chang, Sherry K W Chan, Emily S M Chen, Edwin P F Pang, Simon S Y Lui, Dicky W S Chung, Wai Song Yeung, Roger M K Ng, William T L Lo, Peter B Jones, Pak Sham & Eric Y H Chen. (2018) Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial. The Lancet Psychiatry 5:5, pages 432-442.
Crossref
Crossref
Laura Dellazizzo, Stéphane Potvin, Kingsada Phraxayavong, Pierre Lalonde & Alexandre Dumais. (2018) Avatar Therapy for Persistent Auditory Verbal Hallucinations in an Ultra-Resistant Schizophrenia Patient: A Case Report. Frontiers in Psychiatry 9.
Crossref
Crossref
Jessica W. Y. Yuen, David D. Kim, Ric M. Procyshyn, Randall F. White, William G. Honer & Alasdair M. Barr. (2018) Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review. Frontiers in Neuroscience 12.
Crossref
Crossref
Mirjam Handrack & Alkomiet Hasan. (2018) Medikamentöse Behandlungsresistenz bei der Schizophrenie. InFo Neurologie & Psychiatrie 20:4, pages 36-42.
Crossref
Crossref
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery
15
58
.
Jesus Sainz, Carlos Prieto, Fulgencio Ruso-Julve & Benedicto Crespo-Facorro. (2018) Blood Gene Expression Profile Predicts Response to Antipsychotics. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
Amir Krivoy, Eldar Hochman, Kyra-Verena Sendt, Sarah Hollander, Yael Vilner, Mirjana Selakovic, Abraham Weizman & Michal Taler. (2018) Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment. Schizophrenia Research 192, pages 226-231.
Crossref
Crossref
Andrew Shaker & Rowena Jones. (2017) Clozapine discontinuation in early schizophrenia: a retrospective case note review of patients under an early intervention service. Therapeutic Advances in Psychopharmacology 8:1, pages 3-11.
Crossref
Crossref
Jibran Y. Khokhar, Angela M. Henricks, Emily D.K. Sullivan & Alan I. Green. 2018. Apprentices to Genius: A tribute to Solomon H. Snyder. Apprentices to Genius: A tribute to Solomon H. Snyder
137
162
.
Amir Krivoy, Roy Onn, Yael Vilner, Eldar Hochman, Shira Weizman, Amir Paz, Shmuel Hess, Roi Sagy, Shiri Kimhi-Nesher, Ehud Kalter, Tal Friedman, Zvi Friedman, Gil Bormant, Sharon Trommer, Avi Valevski & Abraham Weizman. (2017) Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial. EBioMedicine 26, pages 138-145.
Crossref
Crossref
Dan Siskind, Victor Siskind & Steve Kisely. (2017) Clozapine Response Rates among People with Treatment-Resistant Schizophrenia: Data from a Systematic Review and Meta-Analysis. The Canadian Journal of Psychiatry 62:11, pages 772-777.
Crossref
Crossref
Carlos Forray & Raimund Buller. (2017) Challenges and opportunities for the development of new antipsychotic drugs. Biochemical Pharmacology 143, pages 10-24.
Crossref
Crossref
Rosalinda C. Roberts. (2017) Postmortem studies on mitochondria in schizophrenia. Schizophrenia Research 187, pages 17-25.
Crossref
Crossref
Claire Foley, Aiden Corvin & Shigeki Nakagome. (2017) Genetics of Schizophrenia: Ready to Translate?. Current Psychiatry Reports 19:9.
Crossref
Crossref
A. Demjaha, J. M. Lappin, D. Stahl, M. X. Patel, J. H. MacCabe, O. D. Howes, M. Heslin, U. A. Reininghaus, K. Donoghue, B. Lomas, M. Charalambides, A. Onyejiaka, P. Fearon, P. Jones, G. Doody, C. Morgan, P. Dazzan & R. M. Murray. (2017) Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors. Psychological Medicine 47:11, pages 1981-1989.
Crossref
Crossref
Susanna Every-Palmer & Pete M Ellis. (2017) Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal ‘Slow Gut’ Reactions, and Comparison with International Drug Safety Advice. CNS Drugs 31:8, pages 699-709.
Crossref
Crossref
Jaime M. Monti, Pablo Torterolo & Seithikurippu R. Pandi Perumal. (2017) The effects of second generation antipsychotic drugs on sleep variables in healthy subjects and patients with schizophrenia. Sleep Medicine Reviews 33, pages 51-57.
Crossref
Crossref
Jian-Ping Zhang & Anil K. Malhotra. (2017) Pharmacogenomics of Antipsychotic Drugs. Current Treatment Options in Psychiatry 4:2, pages 127-138.
Crossref
Crossref
Amir Krivoy, Irit Gil-Ad, Igor Tarasenko, Abraham Weizman & Michal Taler. (2017) Trans-generation enrichment of clozapine-responsiveness trait in mice using a subchronic hypo-glutamatergic model of schizophrenia:A preliminary study. Behavioural Brain Research 323, pages 141-145.
Crossref
Crossref
Makoto Kinoshita, Shusuke Numata, Atsushi Tajima, Hidenaga Yamamori, Yuka Yasuda, Michiko Fujimoto, Shinya Watanabe, Hidehiro Umehara, Shinji Shimodera, Takanobu Nakazawa, Masataka Kikuchi, Akihiro Nakaya, Hitoshi Hashimoto, Issei Imoto, Ryota Hashimoto & Tetsuro Ohmori. (2017) Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia. International Journal of Molecular Sciences 18:3, pages 632.
Crossref
Crossref
Helen Killaspy, Michael King, Frank Holloway, Thomas J Craig, Sarah Cook, Tim Mundy, Gerard Leavey, Paul McCrone, Leonardo Koeser, Rumana Omar, Louise Marston, Maurice Arbuthnott, Nicholas Green, Isobel Harrison, Melanie Lean, Melanie Gee & Sadiq Bhanbhro. (2017) The Rehabilitation Effectiveness for Activities for Life (REAL) study: a national programme of research into NHS inpatient mental health rehabilitation services across England. Programme Grants for Applied Research 5:7, pages 1-284.
Crossref
Crossref
Sarah Tully, Adrian Wells, Melissa Pyle, Jemma Hudson, Andrew Gumley, David Kingdon, Matthias Schwannauer, Douglas Turkington & Anthony P. Morrison. (2017) Measuring common responses to psychosis: Assessing the psychometric properties of a new measure. Schizophrenia Research 181, pages 131-136.
Crossref
Crossref
Takanobu Nakazawa, Masataka Kikuchi, Mitsuru Ishikawa, Hidenaga Yamamori, Kazuki Nagayasu, Takuya Matsumoto, Michiko Fujimoto, Yuka Yasuda, Mikiya Fujiwara, Shota Okada, Kensuke Matsumura, Atsushi Kasai, Atsuko Hayata-Takano, Norihito Shintani, Shusuke Numata, Kazuhiro Takuma, Wado Akamatsu, Hideyuki Okano, Akihiro Nakaya, Hitoshi Hashimoto & Ryota Hashimoto. (2017) Differential gene expression profiles in neurons generated from lymphoblastoid B-cell line-derived iPS cells from monozygotic twin cases with treatment-resistant schizophrenia and discordant responses to clozapine. Schizophrenia Research 181, pages 75-82.
Crossref
Crossref
T Cardozo, E Shmelkov, K Felsovalyi, J Swetnam, T Butler, D Malaspina & S V Shmelkov. (2017) Chemistry-based molecular signature underlying the atypia of clozapine. Translational Psychiatry 7:2, pages e1036-e1036.
Crossref
Crossref
Alex Yow & Mahesh B Jayaram. (2017) Non-clozapine antipsychotic combinations for treatment-resistant schizophrenia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Hye Sung KimSe Hyun KimNam Young LeeTak YounJeoung Hyuk LeeSeunghyun ChungYong Sik KimIn Won Chung. (2017) Effectiveness of Electroconvulsive Therapy Augmentation on Clozapine-Resistant Schizophrenia. Psychiatry Investigation 14:1, pages 58.
Crossref
Crossref
Jessica Foster, John Lally, Victoria Bell & Sukhi Shergill. (2018) Successful clozapine re-challenge in a patient with three previous episodes of clozapine-associated blood dyscrasia. BJPsych Open 3:1, pages 22-25.
Crossref
Crossref
. 2017. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
111
.
Susanna Every-Palmer, Pete M. Ellis, Mike Nowitz, James Stanley, Eve Grant, Mark Huthwaite & Helen Dunn. (2016) The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study. CNS Drugs 31:1, pages 75-85.
Crossref
Crossref
Helen Killaspy, Louise Marston, Nicholas Green, Isobel Harrison, Melanie Lean, Frank Holloway, Tom Craig, Gerard Leavey, Maurice Arbuthnott, Leonardo Koeser, Paul McCrone, Rumana Z. Omar & Michael King. (2016) Clinical outcomes and costs for people with complex psychosis; a naturalistic prospective cohort study of mental health rehabilitation service users in England. BMC Psychiatry 16:1.
Crossref
Crossref
Masumi Tachibana, Tomihisa Niitsu, Motoki Watanabe, Tasuku Hashimoto, Nobuhisa Kanahara, Masatomo Ishikawa & Masaomi Iyo. (2016) Effectiveness of blonanserin for patients with drug treatment-resistant schizophrenia and dopamine supersensitivity: A retrospective analysis. Asian Journal of Psychiatry 24, pages 28-32.
Crossref
Crossref
J. Lally, O. Ajnakina, M. Di Forti, A. Trotta, A. Demjaha, A. Kolliakou, V. Mondelli, T. Reis Marques, C. Pariante, P. Dazzan, S. S. Shergil, O. D. Howes, A. S. David, J. H. MacCabe, F. Gaughran & R. M. Murray. (2016) Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses. Psychological Medicine 46:15, pages 3231-3240.
Crossref
Crossref
Rebecca N.S. Harrison, Robin M. Murray, Sang Hyuck Lee, Jose Paya Cano, David Dempster, Charles J. Curtis, Danai Dima, Fiona Gaughran, Gerome Breen & Simone de Jong. (2016) Gene-expression analysis of clozapine treatment in whole blood of patients with psychosis. Psychiatric Genetics 26:5, pages 211-217.
Crossref
Crossref
Amir Krivoy, Fiona Gaughran, Abraham Weizman, Gerome Breen & James H. MacCabe. (2016) Gene polymorphisms potentially related to the pharmacokinetics of clozapine. International Clinical Psychopharmacology 31:4, pages 179-184.
Crossref
Crossref
Jaime M. Monti. (2016) The effect of second-generation antipsychotic drugs on sleep parameters in patients with unipolar or bipolar disorder. Sleep Medicine 23, pages 89-96.
Crossref
Crossref
Wan Lian LC Chua, Hristo S Grigorov & John Hiley. (2016) Oestrogen (adjunct) versus placebo for women with schizophrenia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Ayala Shirazi, Brendon Stubbs, Lucia Gomez, Susan Moore, Fiona Gaughran, Robert Flanagan, James MacCabe & John Lally. (2016) Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 17:6, pages 863.
Crossref
Crossref
Helio Elkis & Peter F. Buckley. (2016) Treatment-Resistant Schizophrenia. Psychiatric Clinics of North America 39:2, pages 239-265.
Crossref
Crossref
Ganesh Gopalakrishna, Muaid H. Ithman & John Lauriello. (2016) Update on New and Emerging Treatments for Schizophrenia. Psychiatric Clinics of North America 39:2, pages 217-238.
Crossref
Crossref
Tarun Bastiampillai, Arun Gupta & Stephen Allison. (2016) FDA changes clozapine monitoring guidelines: Implications for worldwide practice. Asian Journal of Psychiatry 21, pages 19-20.
Crossref
Crossref
John Lally, John Tully, Dene Robertson, Brendon Stubbs, Fiona Gaughran & James H. MacCabe. (2016) Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis. Schizophrenia Research 171:1-3, pages 215-224.
Crossref
Crossref
S. Cargnin, A. Massarotti & S. Terrazzino. (2020) BDNF Val66Met and clinical response to antipsychotic drugs: A systematic review and meta-analysis. European Psychiatry 33:1, pages 45-53.
Crossref
Crossref
Jaime M. Monti, Pablo Torterolo & Seithikurippu R. Pandi Perumal. 2016. Dopamine and Sleep. Dopamine and Sleep
213
233
.
Florence Elizabeth Chamberlain, Nicholas Walsh & Jan Falkowski. (2018) Chemotherapy for Hodgkin's lymphoma in a patient receiving clozapine for treatment-resistant schizophrenia: use of the Mental Capacity Act 2005. BJPsych Bulletin 39:6, pages 305-307.
Crossref
Crossref
Rudolf N Cardinal, George Savulich, Louisa M Mann & Emilio Fernández-Egea. (2015) Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case register. npj Schizophrenia 1:1.
Crossref
Crossref
M Verbelen, D A Collier, D Cohen, J H MacCabe & C M Lewis. (2015) Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis. The Pharmacogenomics Journal 15:5, pages 461-466.
Crossref
Crossref
Fernando Caravaggio, Margaret Hahn, Shinichiro Nakajima, Philip Gerretsen, Gary Remington & Ariel Graff-Guerrero. (2015) Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophrenia. Medical Hypotheses 85:4, pages 391-396.
Crossref
Crossref
Diarmid JM Sinclair, James MA Ellison & Clive E Adams. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
R. Rajkumar, J. Fam, E.Y.M. Yeo & G.S. Dawe. (2015) Ketamine and suicidal ideation in depression: Jumping the gun?. Pharmacological Research 99, pages 23-35.
Crossref
Crossref
Sean P. Carruthers, Caroline T. Gurvich & Susan L. Rossell. (2015) The muscarinic system, cognition and schizophrenia. Neuroscience & Biobehavioral Reviews 55, pages 393-402.
Crossref
Crossref
William T. O'Connor & Sean D. O'Shea. (2015) Clozapine and GABA transmission in schizophrenia disease models. Pharmacology & Therapeutics 150, pages 47-80.
Crossref
Crossref
Robert J. StantonIIII, Chris Paxos, Werner J. Geldenhuys, B Pharm, Jessica L. Boss, Mark Munetz, Altaf S. Darvesh & M Pharm. (2015) Clozapine underutilization in treatment-resistant schizophrenia. Mental Health Clinician 5:2, pages 63-67.
Crossref
Crossref
Jan P.A.M. Bogers, Hong Bui, Martien Herruer & Dan Cohen. (2015) Capillary compared to venous blood sampling in clozapine treatment: patients? and healthcare practitioners? experiences with a point-of-care device. European Neuropsychopharmacology 25:3, pages 319-324.
Crossref
Crossref
Hannah Steeds, Robin L. Carhart-Harris & James M. Stone. (2014) Drug models of schizophrenia. Therapeutic Advances in Psychopharmacology 5:1, pages 43-58.
Crossref
Crossref
Displaying 200 of 327 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list